These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28888037)

  • 1. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
    Baena-Del Valle JA; Zheng Q; Esopi DM; Rubenstein M; Hubbard GK; Moncaliano MC; Hruszkewycz A; Vaghasia A; Yegnasubramanian S; Wheelan SJ; Meeker AK; Heaphy CM; Graham MK; De Marzo AM
    J Pathol; 2018 Jan; 244(1):11-24. PubMed ID: 28888037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
    J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
    Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
    Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein.
    Zhang X; Lee C; Ng PY; Rubin M; Shabsigh A; Buttyan R
    Prostate; 2000 Jun; 43(4):278-85. PubMed ID: 10861747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
    Koh CM; Khattar E; Leow SC; Liu CY; Muller J; Ang WX; Li Y; Franzoso G; Li S; Guccione E; Tergaonkar V
    J Clin Invest; 2015 May; 125(5):2109-22. PubMed ID: 25893605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
    Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
    Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin targets c-MYC oncogene to prevent prostate cancer.
    Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
    Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression.
    Cayuela ML; Flores JM; Blasco MA
    EMBO Rep; 2005 Mar; 6(3):268-74. PubMed ID: 15731767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread telomere instability in prostatic lesions.
    Tu L; Huda N; Grimes BR; Slee RB; Bates AM; Cheng L; Gilley D
    Mol Carcinog; 2016 May; 55(5):842-52. PubMed ID: 25917938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.
    Bastacky S; Cieply K; Sherer C; Dhir R; Epstein JI
    Hum Pathol; 2004 Mar; 35(3):281-9. PubMed ID: 15017583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of myc and telomerase interactions in vivo.
    Flores I; Evan G; Blasco MA
    Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
    Gurel B; Iwata T; Koh CM; Jenkins RB; Lan F; Van Dang C; Hicks JL; Morgan J; Cornish TC; Sutcliffe S; Isaacs WB; Luo J; De Marzo AM
    Mod Pathol; 2008 Sep; 21(9):1156-67. PubMed ID: 18567993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
    Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
    Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
    Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
    J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
    Kamradt J; Drosse C; Kalkbrenner S; Rohde V; Lensch R; Lehmann J; Fixemer T; Bonkhoff H; Stoeckle M; Wullich B
    Lab Invest; 2003 May; 83(5):623-33. PubMed ID: 12746472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.
    Zhang Y; Calado R; Rao M; Hong JA; Meeker AK; Dumitriu B; Atay S; McCormick PJ; Garfield SH; Wangsa D; Padilla-Nash HM; Burkett S; Zhang M; Kunst TF; Peterson NR; Xi S; Inchauste S; Altorki NK; Casson AG; Beer DG; Harris CC; Ried T; Young NS; Schrump DS
    PLoS One; 2014; 9(7):e101010. PubMed ID: 24983628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.